Florida has become the second U.S. state to ban fluoride in its public water systems, following a controversial trend among Republican-led states. Governor Ron DeSantis signed the legislation on Thursday, calling the addition of fluoride to tap water “forced medication.” The ban takes effect on July 1.
Fluoride, a naturally occurring mineral found in water, soil, and air, has been widely used for decades to prevent cavities and strengthen teeth. About 63% of Americans currently receive fluoridated water, according to the CDC. Public health organizations, including the American Dental Association (ADA), argue that fluoridation significantly improves dental health and poses no proven harm. However, fluoride has faced growing political opposition, especially from figures like DeSantis and Health Secretary Robert F. Kennedy Jr., who link it to health risks such as cancer and reduced cognitive function in children—claims the American Cancer Society says lack strong evidence.
DeSantis, who previously opposed public health mandates during the COVID-19 pandemic, said medical experts “shouldn’t be able to decree how we live our lives,” criticizing what he sees as overreach by health authorities.
Utah became the first state to enact a similar ban in March. Meanwhile, the FDA is currently reviewing the safety of fluoride supplements for children, signaling broader scrutiny of the mineral’s use in public health.
The ADA strongly opposes these moves, urging a thorough review before policy changes are made. President Brett Kessler emphasized the need to “slow down” and fully assess the implications of banning fluoride for national health.
The fluoride debate is intensifying as Republican states challenge long-standing public health practices, raising questions about science, personal choice, and government intervention in health policy.


Bachelet Pushes Forward With UN Secretary-General Bid Despite Chile's Withdrawal
CDC Acting Director Urges Measles Vaccination as U.S. Cases Surge in 2026
Iran-Israel Missile Strikes Continue Amid Mixed Signals on U.S.-Iran Diplomacy
Novartis’ Vanrafia Shows Strong Phase 3 Results in IgA Nephropathy, Paving Way for Full Approval
Trump Backs Down on Iran Strikes After Gulf Allies Sound the Alarm
Palestinian Activist Leqaa Kordia Released from U.S. Immigration Detention After Judge's Order
RFK Jr. Overhauls Federal Autism Panel, Sparking Medical Community Backlash
U.S. Officials Express Optimism Over New CDC Director Selection Amid Vaccine Policy Turmoil
Air Canada Express Crash at LaGuardia: Controller Distracted by Prior Emergency
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
Tesla FSD EU Approval Delayed to April 10 as RDW Completes Final Review
G7 Foreign Ministers Gather in France Amid Global Tensions and U.S. Policy Uncertainty
U.S. Appeals Court Strikes Down FTC Order Against TurboTax "Free" Advertising
WTO Reform Talks Begin in Cameroon Amid Global Trade Tensions
Merck Raises Growth Outlook, Targets $70 Billion Revenue From New Drugs by Mid-2030s
China Escalates BHP Iron Ore Ban Amid Contract Dispute 



